Skip to main content

This job has expired

You will need to login before you can apply for a job.

Associate Director, CMC Project Management

Employer
Intellia Therapeutics
Location
Cambridge, MA
Start date
Oct 8, 2021

View more

Discipline
Clinical, Clinical Project Management, Science/R&D, CMC
Required Education
Masters Degree/MBA
Position Type
Full time
Hotbed
Genetown

Job Details

Why Join Intellia? 

Our mission is to develop curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases. 

Beyond our science, we live our four core values: One, Explore, Disrupt, Deliver and feel strongly that you can achieve more at Intellia. We have a single-minded determination to excel and succeed together. We believe in the power of curiosity and pushing boundaries. We welcome challenging thoughts and imagination to develop innovative solutions. And we know that patients are counting on us to make the promise a reality, so we must maintain high standards and get it done. 

We want all of our people to go beyond what is possible. We aren’t constrained by typical end rails, and we aren’t out to just “treat” people. We’re all in this for something more. We’re driven to cure and motivated for change. Just imagine the possibilities of what we can do together.   

How you will Achieve More with Intellia: 

As Associate Director, CMC Project Management, you will build matrixed teams to drive CMC program strategy and successfully manage program deliverables with a company-wide impact. In this highly visible role, you will be instrumental in building best-in-class business processes and developing robust reporting and analytics to share project updates and measure progress towards reaching milestones. In this role, you will also:

  • Build and manage near- and long-term CMC scope and strategy to advance novel approaches in gene therapy spanning early and late clinical stage programs

  • Define priorities, aligning resources and budgets to execute critical objectives

  • Develop, strategize, and implement effective meeting tools and communication, including CMC documentation such as agendas, meeting minutes, action items, dashboards, risk registers, etc.  

  • Execute scenario planning and risk assessments, brainstorm solutions, and guide decision-making within CMC and Governance Teams

  • Educate leadership and CMC teams on program deliverables and ensure project progress

  • Support management of alliance partnerships and external CMO/CRO relationships by aligning internal and external resources to achieve timelines and milestones

  • Lead by example in setting a dynamic and “One Team” culture and act as technical and operational SME across the entire scope of all projects managed

  • Demonstrate leadership skills in owning projects from planning to closing, holding teams accountable to deliverables, and providing technical input to guide decision-making

  • Act as a key player in cross-management of all ongoing programs  

About You: 

Do you enjoy working in a highly team-oriented and fast-paced role? We’re looking for someone with strong leadership and communication skills who thrives in a dynamic, collaborative environment. Our ideal candidate has experience in biopharmaceutical development of gene therapy products, with an aptitude for strategic project and people management. Other role requirements include: 

  • Advanced degree (MS, PhD or equivalent) in the life sciences, chemical or industrial engineering

  • 10+ years industry experience with >2 years demonstrated project management experience in CMC

  • Six Sigma Green Belt, Agile, or PMP certification desirable 

  • Hands-on experience with pharmaceutical/biotech production processes and environment, technical knowledge of analytical development/qualifications, and regulatory filings is required

  • Experience progressing programs in cell & gene therapy

Meet your Future Team: 

The CMC Strategy and Operations team is an energetic and fun group of people, bringing diverse skills and experience to the table. Our small team operates like a start-up within a start-up, and you can count on your teammates to challenge you to lead, grow and adapt. In addition to being a part of the CMC Strategy and Operations team, you will be a part of a matrixed organization partnering closely within CMC and across research, clinical, regulatory, program management and G&A functions.

This role will report to the Director, CMC Strategy and Operations that oversees Intellia’s full scope and future forecasting of CMC program planning. Given the breadth of work this team supports, you will have the opportunity to explore and lead a wide range of initiatives within TechOps.

We look forward to fostering your skills, learning from your experience, and building a larger team that will make a difference in patient’s lives.

#LI-KO1

Covid-19 Vaccination Policy: Effective Monday, January 3, 2022, all Intellia employees, regardless of work location, must be fully vaccinated for COVID-19. Requests for exemption for medical or sincerely held religious beliefs will be considered.

EEOC Statement: Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.

Company

Many of us pursuing work in the biotechnology industry are inspired by a loved one who is living with a disease or the loss of someone in our community. Rare genetic and oncological and immunological diseases not only affect the people living with often debilitating and life-threatening symptoms, but these disorders also significantly impact their families, friends and caregivers.
 
Our researchers work tirelessly to harness the genome editing technology CRISPR/Cas9 for human therapeutic use. Jennifer Doudna, an Intellia co-founder, and Emmanuelle Charpentier were awarded the 2020 Nobel Prize in Chemistry for their pioneering work in CRISPR. We at Intellia are humbled to have a hand in making what we believe to be medical history. As a leader in this space, we take this responsibility to patients seriously.
 
We are employing a modular genome editing platform to create diverse in vivo and ex vivo pipelines, spanning a range of therapeutic indications. Guided by this full-spectrum approach, we are committed to making CRISPR/Cas9-based medicines a reality for patients suffering from genetic diseases and to creating novel engineered cell therapies for various cancers and autoimmune diseases.

Change life stories with genome editing therapies!

Stock Symbol: NTLA

TwitterInstagram

Company info
Website
Phone
(857) 285-6200
Location
40 Erie Street
Cambridge
Massachusetts
02139
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert